Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How are you integrating the findings from KEYNOTE-689 into daily practice?
Related Questions
What is the role of radiation therapy for Kimura's disease of the parotid and neck?
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?
Would you recommend adjuvant radiation for a patient with head/neck merkel cell carcinoma following a pathologic complete response to neoadjuvant immunotherapy?
What is the preferred neoadjuvant/adjuvant chemotherapy regimen for HPV-associated nasopharyngeal cancer?
How do you counsel patients regarding alcohol consumption following treatment of head and neck cancer?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
What alternatives do you recommend for oral dexamethasone solution for HN cancer?
The 2025 multigroup consensus guidelines for target delineation of NPC recommend GTVp to CTVp expansion of 0mm (previously 5mm in the 2017 guidelines). What do you do in your practice?
How would you manage a presumed radiation induced sarcoma of the head and neck?
For a patient with a salivary gland tumor with evidence of local recurrence would you recommend 6 weekly fractions if giving RT alone?
